Table 1.
Clinical characteristics of study patients.
| GHS (n = 350) | GMS (n = 698) | FMS (n = 431) | |
|---|---|---|---|
| Males (%) | 238 (68.0) | 344 (49.3) | 224 (52.0) |
| Age at recruitment (yrs) | 64.5 ± 8.2 | 61.3 ± 9.9 | 63.2 ± 11.6 |
| Smokers (%) | 58 (16.6) | 102 (14.6) | 71 (16.5) |
| Diabetes duration (yrs) | 13.9 ± 9.2 | 10.3 ± 8.8 | 13.1 ± 10.1 |
| BMI (kg/m2) | 30.1 ± 4.8 | 31.0 ± 5.7 | 30.0 ± 6.1 |
| HbA1C (%), (mmol/mol) | 8.6 ± 1.9, (70 ± 20.8) | 8.7 ± 2.0, (72 ± 21.9) | 9.1 ± 2.2, (76 ± 24.0) |
| Insulin (w/wo) oral agents (%) | 191 (54.6) | 271 (38.8) | 157 (36.4) |
| Anti-hypertension therapy (%) | 296 (84.6) | 323 (46.3) | 291 (67.5) |
| Anti-dyslipidemia therapy (%) | 227 (64.8) | 195 (27.9) | 162 (37.6) |
| Resistin (ng/ml) | 10.7 ± 6.7 | 10.1 ± 8.1 | 8.5 ± 6.2 |
| Follow-up (yrs), (py) | 5.4 ± 2.5; (1,890) | 10.8 ± 3.5; (7,504) | 7.1 ± 2.5; (3,060) |
| Events (n) | 78 | 206 | 119 |
| IR (n. events per 100 py) | 4.1 | 2.7 | 3.9 |
Continuous variables were reported as mean ± SD whereas categorical variables as total frequency and percentages. GHS: Gargano Heart Study; GMS: Gargano Mortality Study; FMS: Foggia Mortality Study; BMI: body mass index; HbA1c: glycated haemoglobin; IR: incidence rate of all-cause death events; py: person-years.